Latest news with #GuernseyEthicsCommittee
Yahoo
27-03-2025
- Health
- Yahoo
Blood from islanders to be used in cancer study
Blood samples from islanders with certain types of cancer will be used in a pioneering piece of research being conducted at the University of Southampton. The study, which was approved last year by the Guernsey Ethics Committee, will combine computer science and medicine to help understand lymphoma and leukaemia better. The research was partly funded by businesses in Guernsey under Cancer Research UK's (CRUK) Business Beats Cancer campaign. Neale Jehan, from CRUK Guernsey, said: "Guernsey residents have played an important role in the ground-breaking research taking place in Southampton over the years and many of our residents have been treated by Southampton clinicians." Mr Jehan said giving researchers access to more patient samples would help "move research forward and discover new ways to treat disease". One part of the study will use nearly 2,000 samples, including people from Guernsey, to develop a "self-trained", computer-based risk score for chronic lymphocytic leukaemia (CLL). CLL is the most common blood cancer in adults. Prof Francesco Forconi, who is leading the project, said the Channel Islands' data would be an "invaluable contribution" and help doctors "prioritise patient well-being and optimise medical resource allocation" in future. Any patients in Guernsey who want to take part in the study should contact his team at the University of Southampton. Follow BBC Guernsey on X and Facebook. Send your story ideas to Woman with cancer giving away 'hope' pendants Cancer patient urges take-up of regular screening Lung cancer is Channel Islands' deadliest cancer University of Southampton Business Beats Cancer - Guernsey
Yahoo
27-03-2025
- Health
- Yahoo
Blood from islanders to be used in cancer study
Blood samples from islanders with certain types of cancer will be used in a pioneering piece of research being conducted at the University of Southampton. The study, which was approved last year by the Guernsey Ethics Committee, will combine computer science and medicine to help understand lymphoma and leukaemia better. The research was partly funded by businesses in Guernsey under Cancer Research UK's (CRUK) Business Beats Cancer campaign. Neale Jehan, from CRUK Guernsey, said: "Guernsey residents have played an important role in the ground-breaking research taking place in Southampton over the years and many of our residents have been treated by Southampton clinicians." Mr Jehan said giving researchers access to more patient samples would help "move research forward and discover new ways to treat disease". One part of the study will use nearly 2,000 samples, including people from Guernsey, to develop a "self-trained", computer-based risk score for chronic lymphocytic leukaemia (CLL). CLL is the most common blood cancer in adults. Prof Francesco Forconi, who is leading the project, said the Channel Islands' data would be an "invaluable contribution" and help doctors "prioritise patient well-being and optimise medical resource allocation" in future. Any patients in Guernsey who want to take part in the study should contact his team at the University of Southampton. Follow BBC Guernsey on X and Facebook. Send your story ideas to Woman with cancer giving away 'hope' pendants Cancer patient urges take-up of regular screening Lung cancer is Channel Islands' deadliest cancer University of Southampton Business Beats Cancer - Guernsey
BBC News
27-03-2025
- Health
- BBC News
Blood from Guernsey residents to be used in cancer study
Blood samples from islanders with certain types of cancer will be used in a pioneering piece of research being conducted at the University of study, which was approved last year by the Guernsey Ethics Committee, will combine computer science and medicine to help understand lymphoma and leukaemia research was partly funded by businesses in Guernsey under Cancer Research UK's (CRUK) Business Beats Cancer Jehan, from CRUK Guernsey, said: "Guernsey residents have played an important role in the ground-breaking research taking place in Southampton over the years and many of our residents have been treated by Southampton clinicians." 'Invaluable contribution' Mr Jehan said giving researchers access to more patient samples would help "move research forward and discover new ways to treat disease".One part of the study will use nearly 2,000 samples, including people from Guernsey, to develop a "self-trained", computer-based risk score for chronic lymphocytic leukaemia (CLL).CLL is the most common blood cancer in Francesco Forconi, who is leading the project, said the Channel Islands' data would be an "invaluable contribution" and help doctors "prioritise patient well-being and optimise medical resource allocation" in patients in Guernsey who want to take part in the study should contact his team at the University of Southampton.
